Symbols / CING Stock $5.35 -2.19% Cingulate Inc.

Healthcare • Biotechnology • United States • NCM
CING (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Shane J. Schaffer Pharm.D.
Exch · Country NCM · United States
Market Cap 65.54M
Enterprise Value 61.44M
Income -22.45M
Sales —
FCF (ttm) -10.43M
Book/sh 0.35
Cash/sh 0.94
Employees 14
Insider 10d —
IPO Dec 08, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -3.68
PEG —
P/S —
P/B 15.46
P/C —
EV/EBITDA -3.17
EV/Sales —
Quick Ratio 1.06
Current Ratio 1.16
Debt/Eq 350.21
LT Debt/Eq —
EPS (ttm) -4.44
EPS next Y -1.46
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-18
Earnings (prior) 2026-03-18
ROA -83.25%
ROE -4.51%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 12.25M
Shs Float 11.29M
Insider Own 35.46%
Instit Own 4.66%
Short Float 14.15%
Short Ratio 2.11
Short Interest 1.42M
52W High 11.89
vs 52W High -55.00%
52W Low 3.20
vs 52W Low 67.19%
Beta -0.77
Impl. Vol. 50.00%
Rel Volume 0.05
Avg Volume 499.56K
Volume 26.63K
Target (mean) $28.70
Tgt Median $31.51
Tgt Low $8.00
Tgt High $55.00
# Analysts 5
Recom None
Prev Close $5.47
Price $5.35
Change -2.19%
About

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$28.70
Mean price target
2. Current target
$5.32
Latest analyst target
3. DCF / Fair value
$-15.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.32
Low
$8.00
High
$55.00
Mean
$28.70

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-08 main Ascendiant Capital Buy → Buy $55
2026-03-23 main Roth Capital Buy → Buy $14
2025-12-08 main Ascendiant Capital Buy → Buy $58
2025-11-19 main Roth Capital Buy → Buy $16
2025-10-15 main Roth Capital Buy → Buy $17
2025-08-22 main Ascendiant Capital Buy → Buy $62
2025-05-27 main Ascendiant Capital Buy → Buy $61
2025-05-19 main Roth Capital Buy → Buy $11
2025-04-21 main Ascendiant Capital Buy → Buy $60
2025-03-06 reit HC Wainwright & Co. Buy → Buy $20
2025-01-30 main HC Wainwright & Co. Buy → Buy $20
2025-01-10 init Roth MKM — → Buy $12
2024-11-20 up Maxim Group Hold → Buy —
2024-01-05 main HC Wainwright & Co. Buy → Buy $8
2023-12-22 down Laidlaw & Co. Buy → Hold —
2023-12-19 down Maxim Group Buy → Hold —
2023-12-18 down Maxim Group Buy → Hold —
News
RSS: Latest CING news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-09 SCHAFFER SHANE J. Chief Executive Officer — 6,862 $0.00 $0
2026-03-09 CALLAHAN JENNIFER L. Chief Financial Officer — 15,329 $0.00 $0
2026-03-09 SILVA RAUL R. Officer — 4,526 $0.00 $0
2026-03-09 BRAMS MATTHEW Officer — 4,526 $0.00 $0
2026-03-09 PATEL NILAY DAHYABHAI J.D. Officer — 5,475 $0.00 $0
2026-02-06 WERTH PETER J. Director — 19,455 $7.70 $149,804
2026-02-06 SCHAFFER SHANE J. Chief Executive Officer — 6,809 $7.70 $52,429
2026-02-06 CALLAHAN JENNIFER L. Chief Financial Officer — 4,864 $7.70 $37,453
2026-02-06 BRAMS MATTHEW Officer — 1,946 $7.70 $14,984
2024-08-15 MYERS LAURIE Chief Operating Officer — 202 $4.16 $841
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
19.94
+27.44%
15.65
-31.26%
22.76
+30.04%
17.50
Research And Development
9.77
+3.48%
9.45
-39.04%
15.49
+72.24%
9.00
Selling General And Administration
10.16
+63.94%
6.20
-14.67%
7.27
-14.59%
8.51
General And Administrative Expense
10.16
+63.94%
6.20
-14.67%
7.27
-14.59%
8.51
Salaries And Wages
2.99
+60.69%
1.86
-29.58%
2.64
+2.08%
2.59
Other Gand A
6.10
+102.93%
3.01
+16.45%
2.58
-8.66%
2.83
Total Expenses
19.94
+27.44%
15.65
-31.26%
22.76
+30.04%
17.50
Operating Income
-19.94
-27.44%
-15.65
+31.26%
-22.76
-30.04%
-17.50
Total Operating Income As Reported
-19.94
-27.44%
-15.64
+31.26%
-22.76
-30.04%
-17.50
EBITDA
-19.40
-29.38%
-14.99
+32.40%
-22.18
-29.62%
-17.11
Normalized EBITDA
-18.25
-30.53%
-13.98
+36.97%
-22.18
-29.62%
-17.11
Reconciled Depreciation
0.54
-17.18%
0.65
+12.04%
0.58
+47.94%
0.39
EBIT
-19.94
-27.44%
-15.65
+31.26%
-22.76
-30.04%
-17.50
Total Unusual Items
-1.15
-13.49%
-1.01
—
—
Total Unusual Items Excluding Goodwill
-1.15
-13.49%
-1.01
—
—
Net Income
-22.45
-35.57%
-16.56
+29.64%
-23.53
-33.14%
-17.68
Pretax Income
-22.45
-35.57%
-16.56
+29.64%
-23.53
-33.14%
-17.68
Net Non Operating Interest Income Expense
-1.36
-1471.61%
0.10
+112.79%
-0.78
-344.52%
-0.17
Net Interest Income
-1.36
-1471.61%
0.10
+112.79%
-0.78
-344.52%
-0.17
Other Income Expense
-1.15
-13.49%
-1.01
—
—
Gain On Sale Of Security
-1.15
-13.49%
-1.01
—
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-22.45
-35.57%
-16.56
+29.64%
-23.53
-33.14%
-17.68
Net Income From Continuing Operation Net Minority Interest
-22.45
-35.57%
-16.56
+29.64%
-23.53
-33.14%
-17.68
Net Income From Continuing And Discontinued Operation
-22.45
-35.57%
-16.56
+29.64%
-23.53
-33.14%
-17.68
Net Income Continuous Operations
-22.45
-35.57%
-16.56
+29.64%
-23.53
-33.14%
-17.68
Normalized Income
-21.30
-37.01%
-15.55
+33.95%
-23.53
-33.14%
-17.68
Net Income Common Stockholders
-22.45
-35.57%
-16.56
+29.64%
-23.53
-33.14%
-17.68
Diluted EPS
—
-4.57
+98.54%
-311.99
+16.67%
-374.40
Basic EPS
—
-4.57
+98.54%
-311.99
+16.67%
-374.40
Basic Average Shares
—
3.40
+4410.25%
0.08
+59.78%
0.05
Diluted Average Shares
—
3.40
+4410.25%
0.08
+59.78%
0.05
Diluted NI Availto Com Stockholders
-22.45
-35.57%
-16.56
+29.64%
-23.53
-33.14%
-17.68
Insurance And Claims
0.74
-24.70%
0.98
-36.23%
1.54
-40.90%
2.61
Rent And Landing Fees
0.33
-5.49%
0.35
-30.24%
0.50
+3.77%
0.48
Rent Expense Supplemental
0.33
-5.49%
0.35
-30.24%
0.50
+3.77%
0.48
Total Other Finance Cost
1.36
+1471.61%
-0.10
-112.79%
0.78
+344.52%
0.17
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
15.07
+1.40%
14.86
+325.74%
3.49
-69.39%
11.41
Current Assets
12.01
-5.15%
12.66
+2088.20%
0.58
-92.65%
7.87
Cash Cash Equivalents And Short Term Investments
10.95
-10.30%
12.21
+23196.93%
0.05
-99.02%
5.36
Cash And Cash Equivalents
10.95
-10.30%
12.21
+23196.93%
0.05
-99.02%
5.36
Other Short Term Investments
—
—
—
0.00
Receivables
0.01
-69.56%
0.03
+80.04%
0.01
-93.76%
0.23
Other Receivables
0.01
-69.56%
0.03
+80.04%
0.01
-93.76%
0.23
Prepaid Assets
0.97
+162.50%
0.37
+18.01%
0.31
-85.54%
2.16
Current Deferred Assets
0.06
0.00
-100.00%
0.18
+78.18%
0.10
Other Current Assets
0.02
-62.27%
0.05
+165.07%
0.02
+0.00%
0.02
Total Non Current Assets
3.07
+39.09%
2.20
-24.35%
2.91
-17.61%
3.54
Net PPE
3.07
+39.09%
2.20
-24.35%
2.91
-17.61%
3.54
Gross PPE
6.90
+25.50%
5.50
-1.01%
5.56
-0.71%
5.60
Accumulated Depreciation
-3.84
-16.41%
-3.30
-24.71%
-2.64
-28.30%
-2.06
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.19
+0.00%
0.19
+2.72%
0.19
+0.00%
0.19
Construction In Progress
0.23
-37.81%
0.38
+80.44%
0.21
-88.05%
1.74
Other Properties
6.00
+34.64%
4.46
-4.94%
4.69
+46.68%
3.20
Leases
0.47
+0.00%
0.47
+0.63%
0.47
+0.00%
0.47
Total Liabilities Net Minority Interest
12.56
+69.58%
7.41
-28.49%
10.36
+37.72%
7.52
Current Liabilities
10.31
+107.41%
4.97
-51.38%
10.23
+45.82%
7.01
Payables And Accrued Expenses
3.32
+70.00%
1.95
-68.77%
6.26
+322.42%
1.48
Payables
2.08
+41.45%
1.47
-72.36%
5.32
+549.36%
0.82
Accounts Payable
2.04
+60.25%
1.27
-75.57%
5.20
+581.98%
0.76
Current Accrued Expenses
1.24
+156.73%
0.48
-48.38%
0.94
+41.65%
0.66
Pensionand Other Post Retirement Benefit Plans Current
0.46
+28.05%
0.36
-40.06%
0.59
+237.66%
0.18
Total Tax Payable
0.04
-78.00%
0.20
+65.88%
0.12
+112.04%
0.06
Current Debt And Capital Lease Obligation
6.53
+145.47%
2.66
-21.12%
3.38
-36.98%
5.36
Current Debt
6.30
+149.14%
2.53
-15.76%
3.00
-40.00%
5.00
Other Current Borrowings
6.30
+149.14%
2.53
—
—
Current Capital Lease Obligation
0.24
+76.82%
0.14
-63.99%
0.38
+5.43%
0.36
Other Current Liabilities
—
—
—
0.34
Total Non Current Liabilities Net Minority Interest
2.25
-7.60%
2.44
+1703.77%
0.14
-73.52%
0.51
Long Term Debt And Capital Lease Obligation
2.25
-7.60%
2.44
+1703.77%
0.14
-73.52%
0.51
Long Term Debt
1.15
-52.75%
2.44
—
—
Long Term Capital Lease Obligation
1.10
0.00
-100.00%
0.14
-73.52%
0.51
Stockholders Equity
2.51
-66.35%
7.46
+208.53%
-6.87
-276.95%
3.88
Common Stock Equity
2.51
-66.35%
7.46
+208.53%
-6.87
-276.95%
3.88
Capital Stock
0.00
+113.24%
0.00
+3300.00%
0.00
-83.61%
0.00
Common Stock
0.00
+113.24%
0.00
+3300.00%
0.00
-83.61%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
7.25
+113.10%
3.40
+3396.97%
0.10
+106.47%
0.05
Ordinary Shares Number
7.25
+113.10%
3.40
+3396.97%
0.10
+106.47%
0.05
Additional Paid In Capital
134.88
+14.91%
117.38
+36.37%
86.07
+17.44%
73.29
Retained Earnings
-132.38
-20.42%
-109.93
-18.27%
-92.94
-33.91%
-69.41
Gains Losses Not Affecting Retained Earnings
0.00
0.00
—
0.00
Other Equity Adjustments
—
—
—
—
Total Equity Gross Minority Interest
2.51
-66.35%
7.46
+208.53%
-6.87
-276.95%
3.88
Total Capitalization
3.66
-63.00%
9.89
+244.01%
-6.87
-276.95%
3.88
Working Capital
1.70
-77.95%
7.69
+179.70%
-9.65
-1225.89%
0.86
Invested Capital
9.96
-19.83%
12.42
+420.96%
-3.87
-143.56%
8.88
Total Debt
8.79
+72.32%
5.10
+45.26%
3.51
-40.16%
5.87
Net Debt
—
—
2.95
—
Capital Lease Obligations
1.34
+891.24%
0.14
-73.52%
0.51
-41.08%
0.87
Net Tangible Assets
2.51
-66.35%
7.46
+208.53%
-6.87
-276.95%
3.88
Tangible Book Value
2.51
-66.35%
7.46
+208.53%
-6.87
-276.95%
3.88
Current Notes Payable
—
2.53
-15.76%
3.00
-40.00%
5.00
Interest Payable
0.56
+3637.05%
0.02
-94.80%
0.29
-0.80%
0.29
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-17.25
+6.54%
-18.45
-22.73%
-15.03
+5.34%
-15.88
Cash Flow From Continuing Operating Activities
-17.25
+6.54%
-18.45
-22.73%
-15.03
+5.34%
-15.88
Net Income From Continuing Operations
-22.45
-35.57%
-16.56
+29.64%
-23.53
-33.14%
-17.68
Depreciation Amortization Depletion
0.54
-17.18%
0.65
+12.04%
0.58
+47.94%
0.39
Depreciation
0.54
-17.18%
0.65
+12.04%
0.58
+47.94%
0.39
Depreciation And Amortization
0.54
-17.18%
0.65
+12.04%
0.58
+47.94%
0.39
Other Non Cash Items
0.35
—
—
—
Stock Based Compensation
1.52
+53.07%
1.00
+22.50%
0.81
+1.48%
0.80
Operating Gains Losses
1.96
+92.99%
1.01
—
—
Gain Loss On Investment Securities
1.15
+13.49%
1.01
—
—
Change In Working Capital
0.83
+118.24%
-4.55
-164.10%
7.10
+1086.87%
0.60
Change In Receivables
0.02
+256.47%
-0.01
-105.32%
0.22
-51.78%
0.46
Change In Prepaid Assets
-0.62
-805.56%
0.09
-95.00%
1.77
+404.41%
-0.58
Change In Payables And Accrued Expense
1.47
+132.33%
-4.54
-187.43%
5.19
+556.59%
0.79
Change In Other Current Assets
-1.24
-562.91%
0.27
+1.57%
0.26
+15.69%
0.23
Change In Other Current Liabilities
1.21
+437.47%
-0.36
-5.40%
-0.34
-14.94%
-0.30
Investing Cash Flow
-0.16
+23.45%
-0.21
+5.49%
-0.22
-46.80%
-0.15
Cash Flow From Continuing Investing Activities
-0.16
+23.45%
-0.21
+5.49%
-0.22
-46.80%
-0.15
Net PPE Purchase And Sale
-0.16
+23.45%
-0.21
+5.49%
-0.22
-46.07%
-0.15
Purchase Of PPE
-0.16
+23.45%
-0.21
+5.49%
-0.22
-46.07%
-0.15
Capital Expenditure
-0.16
+23.45%
-0.21
+5.49%
-0.22
-46.07%
-0.15
Net Investment Purchase And Sale
—
—
0.00
-100.00%
0.00
Purchase Of Investment
—
—
—
—
Sale Of Investment
—
—
0.00
-100.00%
0.00
Net Other Investing Changes
—
—
—
-0.00
Financing Cash Flow
16.15
-47.60%
30.82
+209.62%
9.95
+103.20%
4.90
Cash Flow From Continuing Financing Activities
16.15
-47.60%
30.82
+209.62%
9.95
+103.20%
4.90
Net Issuance Payments Of Debt
6.00
+21.20%
4.95
+65.78%
2.98
-40.14%
4.98
Issuance Of Debt
6.00
+20.87%
4.96
+65.47%
3.00
-40.00%
5.00
Repayment Of Debt
-0.00
+74.04%
-0.02
-6.33%
-0.02
-6.34%
-0.02
Long Term Debt Issuance
6.00
+20.87%
4.96
+65.47%
3.00
-40.00%
5.00
Long Term Debt Payments
-0.00
+74.04%
-0.02
-6.33%
-0.02
-6.34%
-0.02
Net Long Term Debt Issuance
6.00
+21.20%
4.95
+65.78%
2.98
-40.14%
4.98
Short Term Debt Issuance
—
—
3.00
-40.00%
5.00
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
—
3.00
0.00
Net Common Stock Issuance
10.15
-60.76%
25.88
+271.19%
6.97
0.00
Net Other Financing Charges
—
—
—
-0.09
Changes In Cash
-1.26
-110.35%
12.16
+329.25%
-5.30
+52.37%
-11.14
Beginning Cash Position
12.21
+23196.93%
0.05
-99.02%
5.36
-67.52%
16.49
End Cash Position
10.95
-10.30%
12.21
+23196.93%
0.05
-99.02%
5.36
Free Cash Flow
-17.41
+6.73%
-18.66
-22.31%
-15.26
+4.85%
-16.04
Interest Paid Supplemental Data
0.02
+216.40%
0.01
-67.62%
0.02
+2.22%
0.02
Common Stock Issuance
10.15
-60.76%
25.88
+271.19%
6.97
0.00
Issuance Of Capital Stock
10.15
-60.76%
25.88
+271.19%
6.97
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category